Drug/nondrug classification using Support Vector Machines with various feature selection strategies

[1]  Ron Kohavi,et al.  Wrappers for Feature Subset Selection , 1997, Artif. Intell..

[2]  Tingjun Hou,et al.  Drug and Drug Candidate Building Block Analysis , 2010, J. Chem. Inf. Model..

[3]  Bo Ding,et al.  Characterizing Binding of Small Molecules. II. Evaluating the Potency of Small Molecules to Combat Resistance Based on Docking Structures , 2013, J. Chem. Inf. Model..

[4]  Ajay,et al.  Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? , 1998, Journal of medicinal chemistry.

[5]  Anne Mai Wassermann,et al.  Searching for Target-Selective Compounds Using Different Combinations of Multiclass Support Vector Machine Ranking Methods, Kernel Functions, and Fingerprint Descriptors , 2009, J. Chem. Inf. Model..

[6]  Tudor I. Oprea,et al.  Understanding drug‐likeness , 2011 .

[7]  F. Petersen,et al.  Natural compounds as drugs , 2008 .

[8]  Thomas Gärtner,et al.  Ligand Prediction from Protein Sequence and Small Molecule Information Using Support Vector Machines and Fingerprint Descriptors , 2009, J. Chem. Inf. Model..

[9]  I. Muegge.  Selection criteria for drug‐like compounds , 2003, Medicinal research reviews.

[10]  Tudor I. Oprea,et al.  Is There a Difference between Leads and Drugs? A Historical Perspective , 2001, J. Chem. Inf. Comput. Sci..

[11]  Xin Chen,et al.  Effect of Molecular Descriptor Feature Selection in Support Vector Machine Classification of Pharmacokinetic and Toxicological Properties of Chemical Agents , 2004, J. Chem. Inf. Model..

[12]  Kathrin Heikamp,et al.  Potency-directed similarity searching using support vector machines , 2011, Journal of Cheminformatics.

[13]  Jean-Philippe Vert,et al.  Virtual screening of GPCRs: An in silico chemogenomics approach , 2008, BMC Bioinformatics.

[14]  Hong Liu,et al.  Computational Screening for Active Compounds Targeting Protein Sequences: Methodology and Experimental Validation , 2011, J. Chem. Inf. Model..

[15]  Yanli Wang,et al.  Binary Classification of Aqueous Solubility Using Support Vector Machines with Reduction and Recombination Feature Selection , 2011, J. Chem. Inf. Model..

[16]  Hisashi Kashima,et al.  Marginalized Kernels Between Labeled Graphs , 2003, ICML.

[17]  Zhi-Wei Cao,et al.  Effect of Selection of Molecular Descriptors on the Prediction of Blood-Brain Barrier Penetrating and Nonpenetrating Agents by Statistical Learning Methods , 2005, J. Chem. Inf. Model..

[18]  Gunnar Rätsch,et al.  Classifying 'Drug-likeness' with Kernel-Based Learning Methods , 2005, J. Chem. Inf. Model..

[19]  Michael C. Hutter,et al.  Gradual in Silico Filtering for Druglike Substances , 2008, J. Chem. Inf. Model..

[20]  Pierre Baldi,et al.  One- to Four-Dimensional Kernels for Virtual Screening and the Prediction of Physical, Chemical, and Biological Properties , 2007, J. Chem. Inf. Model..

[21]  Peter Lind,et al.  Support Vector Machines for the Estimation of Aqueous Solubility , 2003, J. Chem. Inf. Comput. Sci..

[22]  S. Muresan,et al.  Investigation of the relationship between topology and selectivity for druglike molecules. , 2010, Journal of medicinal chemistry.

[23]  Jean-Philippe Vert,et al.  The Pharmacophore Kernel for Virtual Screening with Support Vector Machines , 2006, J. Chem. Inf. Model..

[24]  Tingjun Hou,et al.  ADME Evaluation in Drug Discovery, 7. Prediction of Oral Absorption by Correlation and Classification , 2007, J. Chem. Inf. Model..

[25]  Uko Maran,et al.  DrugLogit: Logistic Discrimination between Drugs and Nondrugs Including Disease-Specificity by Assigning Probabilities Based on Molecular Properties , 2012, J. Chem. Inf. Model..

[26]  Ruili Huang,et al.  Structure Based Model for the Prediction of Phospholipidosis Induction Potential of Small Molecules , 2012, J. Chem. Inf. Model..

[27]  Pickett,et al.  Computational methods for the prediction of 'drug-likeness' , 2000, Drug discovery today.

[28]  Bo-Han Su,et al.  Predictive Toxicology Modeling: Protocols for Exploring hERG Classification and Tetrahymena pyriformis End Point Predictions , 2012, J. Chem. Inf. Model..

[29]  Kathrin Heikamp,et al.  Prediction of Activity Cliffs Using Support Vector Machines , 2012, J. Chem. Inf. Model..

[30]  Corinna Cortes,et al.  Support-Vector Networks , 1995, Machine Learning.

[31]  Shigeyuki Yokoyama,et al.  In silico functional profiling of small molecules and its applications. , 2008, Journal of medicinal chemistry.

[32]  Ulrich Rester,et al.  From virtuality to reality - Virtual screening in lead discovery and lead optimization: a medicinal chemistry perspective. , 2008, Current opinion in drug discovery & development.

[33]  Bernhard Schölkopf,et al.  Learning Theory and Kernel Machines , 2003, Lecture Notes in Computer Science.

[34]  Hualin Xi,et al.  Predicting Kinase Selectivity Profiles Using Free-Wilson QSAR Analysis , 2008, J. Chem. Inf. Model..

[35]  Andreas Bender,et al.  Handbook of Chemoinformatics Algorithms , 2010 .

[36]  T. Ritchie,et al.  The impact of aromatic ring count on compound developability--are too many aromatic rings a liability in drug design? , 2009, Drug discovery today.

[37]  Igor V. Pletnev,et al.  Drug Discovery Using Support Vector Machines. The Case Studies of Drug-likeness, Agrochemical-likeness, and Enzyme Inhibition Predictions , 2003, J. Chem. Inf. Comput. Sci..

[38]  Wei Wang,et al.  Characterization of domain-peptide interaction interface: prediction of SH3 domain-mediated protein-protein interaction network in yeast by generic structure-based models. , 2012, Journal of proteome research.

[39]  Tatsuya Akutsu,et al.  Graph Kernels for Molecular Structure-Activity Relationship Analysis with Support Vector Machines , 2005, J. Chem. Inf. Model..

[40]  John Bradshaw,et al.  Identification of Biological Activity Profiles Using Substructural Analysis and Genetic Algorithms , 1998, J. Chem. Inf. Comput. Sci..

[41]  Daniel Kuhn,et al.  Combining Global and Local Measures for Structure-Based Druggability Predictions , 2012, J. Chem. Inf. Model..

[42]  George Papadatos,et al.  Evaluation of machine-learning methods for ligand-based virtual screening , 2007, J. Comput. Aided Mol. Des..

[43]  Wei Zhang,et al.  Recent advances in computational prediction of drug absorption and permeability in drug discovery. , 2006, Current medicinal chemistry.

[44]  Tingjun Hou,et al.  ADME evaluation in drug discovery , 2002, Journal of molecular modeling.

[45]  Anne Mai Wassermann,et al.  Ligand Prediction for Orphan Targets Using Support Vector Machines and Various Target-Ligand Kernels Is Dominated by Nearest Neighbor Effects , 2009, J. Chem. Inf. Model..

[46]  Ian H. Witten,et al.  Data mining: practical machine learning tools and techniques, 3rd Edition , 1999 .

[47]  Ian H. Witten,et al.  The WEKA data mining software: an update , 2009, SKDD.

[48]  Lin-Li Li,et al.  ID-Score: A New Empirical Scoring Function Based on a Comprehensive Set of Descriptors Related to Protein-Ligand Interactions , 2013, J. Chem. Inf. Model..

[49]  Tingjun Hou,et al.  Recent developments of in silico predictions of intestinal absorption and oral bioavailability. , 2009, Combinatorial chemistry & high throughput screening.

[50]  Dimitar Hristozov,et al.  Exploring Potency and Selectivity Receptor Antagonist Profiles Using a Multilabel Classification Approach: The Human Adenosine Receptors as a Key Study , 2009, J. Chem. Inf. Model..

[51]  V. Sridhar,et al.  Substructure-Based Support Vector Machine Classifiers for Prediction of Adverse Effects in Diverse Classes of Drugs , 2006, J. Chem. Inf. Model..

[52]  Yoshimasa Takahashi,et al.  Predictive Activity Profiling of Drugs by Topological-Fragment-Spectra-Based Support Vector Machines , 2008, J. Chem. Inf. Model..

[53]  Tingjun Hou,et al.  ADME Evaluation in Drug Discovery, 6. Can Oral Bioavailability in Humans Be Effectively Predicted by Simple Molecular Property-Based Rules? , 2007, J. Chem. Inf. Model..

[54]  Jie Shen,et al.  Estimation of ADME Properties with Substructure Pattern Recognition , 2010, J. Chem. Inf. Model..

[55]  William J. Welsh,et al.  New Predictive Models for Blood–Brain Barrier Permeability of Drug-like Molecules , 2008, Pharmaceutical Research.

[56]  Vladimir N. Vapnik,et al.  The Nature of Statistical Learning Theory , 2000, Statistics for Engineering and Information Science.

[57]  Xianghui Liu,et al.  SVM Model for Virtual Screening of Lck Inhibitors , 2009, J. Chem. Inf. Model..

[58]  George Karypis,et al.  Assessing Synthetic Accessibility of Chemical Compounds Using Machine Learning Methods , 2010, J. Chem. Inf. Model..

[59]  Stephen R. Johnson,et al.  Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.

[60]  Yoshua Bengio,et al.  Collaborative Filtering on a Family of Biological Targets , 2006, J. Chem. Inf. Model..

[61]  Hui Zhang,et al.  Rapid and accurate assessment of seizure liability of drugs by using an optimal support vector machine method. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.

[62]  Ian Witten,et al.  Data Mining , 2000 .

[63]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[64]  Tingjun Hou,et al.  ADME Evaluation in Drug Discovery, 8. The Prediction of Human Intestinal Absorption by a Support Vector Machine , 2007, J. Chem. Inf. Model..

[65]  Bo Wang,et al.  Support Vector Regression Scoring of Receptor-Ligand Complexes for Rank-Ordering and Virtual Screening of Chemical Libraries , 2011, J. Chem. Inf. Model..

[66]  Pritish Kumar Varadwaj,et al.  A prediction model for oral bioavailability of drugs using physicochemical properties by support vector machine , 2011, Journal of natural science, biology, and medicine.

[67]  Lars Carlsson,et al.  Beyond the Scope of Free-Wilson Analysis: Building Interpretable QSAR Models with Machine Learning Algorithms , 2013, J. Chem. Inf. Model..

[68]  Chunhua Zhang,et al.  Kernel-based data fusion improves the drug-protein interaction prediction , 2011, Comput. Biol. Chem..

[69]  Tingjun Hou,et al.  Drug-likeness analysis of traditional Chinese medicines: prediction of drug-likeness using machine learning approaches. , 2012, Molecular pharmaceutics.

[70]  R. García-Domenech,et al.  General topological patterns of known drugs. , 2001, Journal of molecular graphics & modelling.

[71]  A. Yan,et al.  In Silico Models to Discriminate Compounds Inducing and Noninducing Toxic Myopathy , 2012, Molecular informatics.

[72]  H. Kubinyi,et al.  A scoring scheme for discriminating between drugs and nondrugs. , 1998, Journal of medicinal chemistry.

[73]  Gokmen Zararsiz,et al.  Bagging Support Vector Machines for Leukemia Classification , 2012 .

[74]  Kathrin Heikamp,et al.  Support vector machines for drug discovery , 2014, Expert opinion on drug discovery.

[75]  Ola Engkvist,et al.  Molecular Topology Analysis of the Differences between Drugs, Clinical Candidate Compounds, and Bioactive Molecules , 2010, J. Chem. Inf. Model..

[76]  Michael Williams,et al.  Drug Discovery and Development , 1987, Humana Press.

[77]  Michael K. Gilson,et al.  Virtual Screening of Molecular Databases Using a Support Vector Machine , 2005, J. Chem. Inf. Model..

[78]  G. Bemis,et al.  The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.

[79]  Sheng Tian,et al.  ADME evaluation in drug discovery. 9. Prediction of oral bioavailability in humans based on molecular properties and structural fingerprints. , 2011, Molecular pharmaceutics.

[80]  Jean-Philippe Vert,et al.  Protein-ligand interaction prediction: an improved chemogenomics approach , 2008, Bioinform..

[81]  Jürgen Bajorath,et al.  Mining of Randomly Generated Molecular Fragment Populations Uncovers Activity-Specific Fragment Hierarchies , 2007, J. Chem. Inf. Model..

[82]  Pierre Baldi,et al.  Graph kernels for chemical informatics , 2005, Neural Networks.

[83]  Qian Li,et al.  Drug-likeness analysis of traditional Chinese medicines: 1. property distributions of drug-like compounds, non-drug-like compounds and natural compounds from traditional Chinese medicines , 2012, Journal of Cheminformatics.

[84]  Klaus-Robert Müller,et al.  StructRank: A New Approach for Ligand-Based Virtual Screening , 2011, J. Chem. Inf. Model..

[85]  Wei Zhang,et al.  Characterization of Domain-Peptide Interaction Interface , 2009, Molecular & Cellular Proteomics.

[86]  Ruili Huang,et al.  Predictive Models for Cytochrome P450 Isozymes Based on Quantitative High Throughput Screening Data , 2011, J. Chem. Inf. Model..

[87]  Jens Sadowski,et al.  Comparison of Support Vector Machine and Artificial Neural Network Systems for Drug/Nondrug Classification , 2003, J. Chem. Inf. Comput. Sci..

[88]  Lei Chen,et al.  Drug-likeness analysis of traditional Chinese medicines: 2. Characterization of scaffold architectures for drug-like compounds, non-drug-like compounds, and natural compounds from traditional Chinese medicines , 2013, Journal of Cheminformatics.

[89]  Ajay.  Predicting drug-likeness: why and how? , 2002, Current topics in medicinal chemistry.

[90]  Kathrin Heikamp,et al.  Prediction of Compounds with Closely Related Activity Profiles Using Weighted Support Vector Machine Linear Combinations , 2013, J. Chem. Inf. Model..

[91]  Jürgen Bajorath,et al.  Scaffold Distributions in Bioactive Molecules, Clinical Trials Compounds, and Drugs , 2010, ChemMedChem.

[92]  Didier Rognan,et al.  Enhancing the Accuracy of Chemogenomic Models with a Three-Dimensional Binding Site Kernel , 2011, J. Chem. Inf. Model..

[93]  Klaus Obermayer,et al.  Molecule Kernels: A Descriptor- and Alignment-Free Quantitative Structure-Activity Relationship Approach , 2008, J. Chem. Inf. Model..

[94]  Shivani Agarwal,et al.  Ranking Chemical Structures for Drug Discovery: A New Machine Learning Approach , 2010, J. Chem. Inf. Model..

[95]  Wei-Ke Lv,et al.  Prediction of acetylcholinesterase inhibitors and characterization of correlative molecular descriptors by machine learning methods. , 2010, European journal of medicinal chemistry.

[96]  Jason Weston,et al.  Gene Selection for Cancer Classification using Support Vector Machines , 2002, Machine Learning.